Epicrispr Biotechnologies jobs, careers, and hiring context

Explore Epicrispr Biotechnologies careers: 2 open roles hiring now. Find jobs at Epicrispr Biotechnologies with direct links to apply. Funding stage: Series C. Headcount: 11-50. Epicrispr Biotechnologies is a South San Francisco-based gene therapy company developing epigenetic medicines using its GEMS (Gene Expression Modulation System) platform, founded on CRISPR science from Stanford's Stanley Qi. Its lead program targets facioscapulohumeral muscular dystrophy (FSHD), a rare muscle-wasting disease, with an FDA-cleared IND for EPI-321.

This page summarizes open roles, company profile signals, and official application paths so candidates can quickly evaluate fit before applying. Use the role list below to identify team focus, review location patterns, and jump to source listings. For broader comparison across the market, continue to the full company directory and jobs explorer.

Browse all jobsBack to companies
Open roles
2
Funding stage
Series C
Total funding
Undisclosed

Key facts

Epicrispr Biotechnologies is a Series C stage AI startup, founded in 2018. Its most recent round was a $90M Series C in Aug 2026. It currently lists 2 open roles across South San Francisco, California, United States, Epicrispr Biotechnologies. Source: Fast AI Jobs company dataset, updated Sep 2026.

Related topic tags

BiotechHealthcare

Sample open roles from this company

Role links below go directly to official listing pages. Use them as a fast path while the full interactive view loads.

More Series C AI startups hiring

CesiumAstro (246)Plata Card (197)Neko Health (106)TRM Labs (106)Figure AI (102)Mercor (99)

Company profile last updated on Sep 9, 2026.